NEW YORK, Dec. 2, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”   NYSE Content Advisory: Pre-Market Update + SEC Chairman Paul Atkins to Deliver Keynote on Capital Markets jwplayer(‘myplayer1’).setup({file: ‘https://mma.prnasia.com/media2/2836488/NYSE_Market_Update_12_2.mp4’, image: ‘https://mma.prnasia.com/media2/2836488/NYSE_Market_Update_12_2.mp4?p=thumbnail’, autostart:’false’, stretching : ‘uniform’, width: ‘512’, height: ‘288’});

Kristen Scholer delivers the pre-market update on December 2nd

Stocks opened Tuesday in positive territory after Monday’s fractional losses, following their strongest holiday-shortened week since May. Risk-off sentiment persists amid a crypto slump, sticky inflation concerns, lofty valuations, and questions around AI-driven returns. SEC Chairman Paul Atkins will ring the Opening Bell and later deliver a keynote at the NYSE, addressing IPO markets, disclosure modernization, and the evolution of U.S. capital markets. Chair Atkins’ remarks and the Opening Bell ceremony will be streamed on the NYSE TV App starting at 9 AM ET.

Opening BellThe Honorable Paul S. Atkins, Chairman of the U.S. Securities and Exchange Commission, will ring The Opening Bell

Closing BellUnited Way kicks off this year’s season of giving

Click here to download the NYSE TV App

 

Video – https://mma.prnasia.com/media2/2836488/NYSE_Market_Update_12_2.mp4

 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Zithara.AI Forays into Australia

Onboards ‘Ernesto Buono Fine Jewellery‘ as the first customer in Australia Unveils…

SentiPulse Launches SentiCat, Positioning Agents as the Foundation for Digital Humans

Agents Serve as a Capability Layer, with SentiCat Marking an Early Step…

The Annals of Oncology Publishes Results of Phase II Study of Sacituzumab Tirumotecan Monotherapy for Urothelial Carcinoma

CHENGDU, China, Nov. 28, 2025 /PRNewswire/ — Recently, Clinical study results from…